Skip to Main Content

Author Details

Rishi J Desai
Harvard Medical School
2011
160
33
PMIDPaper TitleJournal TitlePublished Year
37839687Comparative Safety and Effectiveness of Warfarin or Rivaroxaban Versus Apixaban in Patients With Advanced CKD and Atrial Fibrillation: Nationwide US Cohort Study.Am J Kidney Dis2024
37654015Improving the accuracy of automated gout flare ascertainment using natural language processing of electronic health records and linked Medicare claims data.Pharmacoepidemiol Drug Saf2024
36191759Risk of Acute Kidney Injury Among Older Adults With Heart Failure and With Reduced Ejection Fraction Treated With Angiotensin-Neprilysin Inhibitor vs Renin-Angiotensin System Inhibitor in Routine Clinical Care.J Card Fail2023
37775970Real-World Treatment Effectiveness of Disease-Modifying Antirheumatic Drugs by Serostatus Among Patients With Rheumatoid Arthritis.ACR Open Rheumatol2023
35616586Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study.Clin Exp Rheumatol2023
37259575Sodium-glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study.Eur Heart J2023
37449570Initiation Patterns of Disease-Modifying Antirheumatic Drugs That Have Potential to Exacerbate Heart Failure.J Am Heart Assoc2023
36943798Comparative Safety of Gout Treatment Strategies on Cardiovascular Outcomes Using Observational Data: Clone-censor-weight Target Trial Emulation Approach.Epidemiology2023
37340238Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review.Drug Saf2023
37097356Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32 Clinical Trials.JAMA2023
37227387Examination of Initiation Patterns for Sacubitril/Valsartan Among Older Adults With HFrEF in the United States.JACC Heart Fail2023
37026443The Impact of Longitudinal Data-Completeness of Electronic Health Record Data on the Prediction Performance of Clinical Risk Scores.Clin Pharmacol Ther2023
36577843Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's disease.Mol Psychiatry2023
36464785Prospective validation of a dynamic prognostic model for identifying COVID-19 patients at high risk of rapid deterioration.Pharmacoepidemiol Drug Saf2023
36603981Finerenone in chronic kidney disease and type 2 diabetes: the known and the unknown.Kidney Int2023
33387667Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease.Clin Gastroenterol Hepatol2022
35772915Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis.J Am Coll Cardiol2022
35771381Predictors of Treatment Change Among Patients with Rheumatoid Arthritis Treated with TNF Inhibitors as First-Line Biologic Agent in the USA: A Cohort Study from Longitudinal Electronic Health Records.BioDrugs2022
35579813Applying Machine Learning in Distributed Data Networks for Pharmacoepidemiologic and Pharmacovigilance Studies: Opportunities, Challenges, and Considerations.Drug Saf2022
35643956Tofacitinib and Risk of Malignancy: Results From the Safety of Tofacitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA) Study.Arthritis Rheumatol2022
35394510Comparative Risk of Alzheimer Disease and Related Dementia Among Medicare Beneficiaries With Rheumatoid Arthritis Treated With Targeted Disease-Modifying Antirheumatic Agents.JAMA Netw Open2022
35689603Sacubitril/valsartan use patterns among older adults with heart failure in clinical practice: a population-based cohort study of >25â¿¿000 Medicare beneficiaries.Eur J Heart Fail2022
35387877Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn's disease.Gut2022
36150454Comparative effectiveness of Empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical care.Am Heart J2022
35868493Gastrointestinal prophylaxis for COVID-19: an illustration of severe bias arising from inappropriate comparators in observational studies.J Clin Epidemiol2022
36330433No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines study.Brain Commun2022
35333307Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study.Rheumatology (Oxford)2022
35114384Rates of Spironolactone Initiation and Subsequent Hyperkalemia Hospitalizations in Patients with Heart Failure with Preserved Ejection Fraction Following the TOPCAT trial: A Cohort Study of Medicare Beneficiaries.J Card Fail2022
35027405Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study.Ann Rheum Dis2022
34498314Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy.Pharmacoepidemiol Drug Saf2022
34643225Trajectories of Prescription Opioid Utilization During Pregnancy Among Prepregnancy Chronic Users and Risk of Neonatal Opioid Withdrawal Syndrome.Am J Epidemiol2022
34571068Use of Anticoagulants and Dosing Appropriateness of Apixaban for New-Onset Atrial Fibrillation Among Hemodialysis Patients.Am J Kidney Dis2022
34100235Secular Trends in the Pharmacologic Treatment of Osteoporosis and Malignancy-Related Bone Disease from 2009 to 2020.J Gen Intern Med2022
34027993Calibrating Real-World Evidence Studies Against Randomized Trials: Treatment Effectiveness of Infliximab in Crohn's Disease.Clin Pharmacol Ther2022
33973371Risk of Hospitalization for Serious Infection After Initiation of Ustekinumab or Other Biologics in Patients With Psoriasis or Psoriatic Arthritis.Arthritis Care Res (Hoboken)2022
33450136Development of a Medicare Claims-Based Model to Predict Persistent High-Dose Opioid Use After Total Knee Replacement.Arthritis Care Res (Hoboken)2022
33383232Prescription opioid use after vaginal delivery and subsequent persistent opioid use and misuse.Am J Obstet Gynecol MFM2021
33764153Updated Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol.J Am Heart Assoc2021
33568363Association of first trimester prescription opioid use with congenital malformations in the offspring: population based cohort study.BMJ2021
33752237Risk of venous thromboembolism associated with tofacitinib in patients with rheumatoid arthritis: a population-based cohort study.Rheumatology (Oxford)2021
33751058The Patterns of Use of Medications for Inflammatory Bowel Disease During Pregnancy in the US and Sweden Are Changing.Inflamm Bowel Dis2021
34931012Broadening the reach of the FDA Sentinel system: A roadmap for integrating electronic health record data in a causal analysis framework.NPJ Digit Med2021
34814147Medication Burden and Prescribing Patterns in Patients on Hemodialysis in the USA, 2013-2017.Am J Nephrol2021
34757241Risk of venous thromboembolism associated with methotrexate versus hydroxychloroquine for rheumatoid arthritis: A propensity score-matched cohort study.Semin Arthritis Rheum2021
34797367Influenza Vaccine Uptake in the Year After Concurrent vs Separate Influenza and Zoster Immunization.JAMA Netw Open2021
34088766Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical care.Heart2021
34086825External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure.PLoS One2021
34196497Comparative Risk of Nonvertebral Fractures Among Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs.ACR Open Rheumatol2021
33944925Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs.JAMA Netw Open2021
33462611Prevalence, incidence and cause-specific mortality of rheumatoid arthritis-associated interstitial lung disease among older rheumatoid arthritis patients.Rheumatology (Oxford)2021
  • 1 - 50 of 160

Recommended Authors

Kathleen M Andersen
Collegeville
Career Start Year 2015
Number of shared co-authors 1
Erica A Voss
Erasmus University Medical Center
Career Start Year 2014
Number of shared co-authors 5
Lana Y H Lai
The University of Manchester, University of Manchester
Career Start Year 2013
Number of shared co-authors 4
James Weaver
Janssen Pharmaceutical Research & Development
Career Start Year 2011
Number of shared co-authors 6
Patrick B Ryan
Columbia University Irving Medical Center
Career Start Year 2010
Number of shared co-authors 13
Wallis C Y Lau
The University of Hong Kong
Career Start Year 2008
Number of shared co-authors 1
James S Floyd
Cardiovascular Health Research Unit, University of Washington
Career Start Year 2008
Number of shared co-authors 6
Craig W Newcomb
University of Pennsylvania Perelman School of Medicine
Career Start Year 2007
Number of shared co-authors 1
Raluca Ionescu-Ittu
Analysis Group Inc.
Career Start Year 2007
Number of shared co-authors 0
Jeremy A Rassen
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2006
Number of shared co-authors 10
Robert A Greevy
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 2
Christianne L Roumie
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 3
Christine Y Lu
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year 2004
Number of shared co-authors 4
Michele Jonsson Funk
University of North Carolina at Chapel Hill
Career Start Year 2002
Number of shared co-authors 2
Nilay D Shah
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 1
Jalpa A Doshi
University of Pennsylvania Perelman School of Medicine
Career Start Year 2002
Number of shared co-authors 2
Martijn J Schuemie
University of California los angeles
Career Start Year 2001
Number of shared co-authors 8
Soko Setoguchi
Rutgers University Institute for Health, the State University of New Jersey
Career Start Year 2001
Number of shared co-authors 7
Joseph S Ross
Yale School of Medicine
Career Start Year 1999
Number of shared co-authors 4
Eric McArthur
Lawson Health Research Institute
Career Start Year 1999
Number of shared co-authors 1
Nicole L Pratt
Quality Use of Medicines and Pharmacy Research Centre, University of South Australia
Career Start Year 1998
Number of shared co-authors 9
Emily Beth Devine
University of Washington
Career Start Year 1997
Number of shared co-authors 3
Matthew A Weir
Western University
Career Start Year 1996
Number of shared co-authors 0
Daniel R Morales
University of Dundee
Career Start Year 1996
Number of shared co-authors 5
George Caleb Alexander
Institute of General Practice and Family Medicine, University Hospital
Career Start Year 1996
Number of shared co-authors 3
Rachel Weinstein
Rush University Medical Center
Career Start Year 1995
Number of shared co-authors 1
David Madigan
Columbia University.
Career Start Year 1990
Number of shared co-authors 7
Mark G Weiner
Weill Cornell Medical College
Career Start Year 1987
Number of shared co-authors 7
Muhammad Mamdani
Institute of Health Policy, University of Toronto
Career Start Year 1984
Number of shared co-authors 1
Elizabeth A Chrischilles
University of Iowa, School of Public Health
Career Start Year 1982
Number of shared co-authors 8

Collaborators

Sebastian Schneeweiss
Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Co-authored papers 34
Elisabetta Patorno
Harvard Medical School
Co-authored papers 33
Joshua J Gagne
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Co-authored papers 24
Shirley V Wang
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 14
Ameet Sarpatwari
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Co-authored papers 8
Michael E Weinblatt
Co-authored papers 6
Sengwee Toh
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 6
Katherine P Liao
Co-authored papers 5
Yoonyoung Park
Moderna Inc.
Co-authored papers 5
Justin Bohn
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 5
Seanna Vine
Co-authored papers 4
Aaron S Kesselheim
Brigham and Women's Hospital.
Co-authored papers 4
James R Rogers
Columbia University
Co-authored papers 3
Jeffrey N Katz
Orthopedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital
Co-authored papers 3
Nancy A Shadick
Co-authored papers 2
Matthew L Maciejewski
Duke University
Co-authored papers 2
Michael Nguyen
Center for Drug Evaluation and Research
Co-authored papers 2
Zhi Yu
Co-authored papers 2
Shawn N Murphy
Harvard Medical School
Co-authored papers 2
Judith C Maro
Harvard Pilgrim Health Care Institute and Harvard Medical School
Co-authored papers 2
Jenna M Reps
Erasmus University Medical Center
Co-authored papers 1
Marian S McDonagh
Oregon Health & Science University
Co-authored papers 1
Jeffrey S Brown
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 1
Sharon E Davis
Vanderbilt University Medical Center
Co-authored papers 1
Tracy J Doyle
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 1
Gregg C Fonarow
David Geffen School of Medicine, University of California, Los Angeles Medical Center
Co-authored papers 1
Lesley H Curtis
Duke Clinical Research Institute
Co-authored papers 1
Daniel Prieto-Alhambra
University of Oxford
Co-authored papers 1
Myriam Gorospe
National Institute on Aging (NIA), National Institutes of Health (NIH)
Co-authored papers 1
Albert-L??szl?? Barab??si
Network Science Institute, Northeastern University
Co-authored papers 1
Release 1.2